title: [The antiallergic eye drops "polynadyme": development, experimental and clinical studies].
abstract: The antiallergic eye drops "Polynadyme", proposed by the Helmgolz Moscow Research Institute of Eye Diseases, have been prepared by the "Sintez" PJSC (Kurgan). The drops exert a combination of antihistaminic and vasoconstrictive effects and, for better tolerability, contain a low-toxic preserving complex. The drops are polymer-based, which ensures a long action and an artificial tear effect. Preclinical rabbit trials have shown the safety of the "Polynadyme" eye drops, their specific activity in preventing an allergic reaction, and their antiallergic effect on a model of allergic conjunctivitis. Comparative clinical trials covering 150 patients have yielded excellent and good results in 93% of cases. In acute allergic reactions, hyperemia, itch, and burning diminished just 5 minutes after administration. The "Polynadyme" eye drops are effective in treating pollinous conjunctivitis, spring (vernal) keratoconjunctivitis, allergic reactions when wearing contact lenses, the dry eye syndrome, drug-induced and toxicoallergic conjunctivitis, and other ocular allergic reactions.
authors.forename: Iu F
authors.initials: IuF
authors.lastname: Maĭchuk
authors.forename: V I
authors.initials: VI
authors.lastname: Pozdniakov
authors.forename: V V
authors.initials: VV
authors.lastname: Pozdniakova
authors.forename: L N
authors.initials: LN
authors.lastname: Iakushina
mesh_terms: D000818:Animals; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D005500:Follow-Up Studies; D006633:Histamine Antagonists / Q000008:administration & dosage*; D006801:Humans; D009883:Ophthalmic Solutions; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D006633:Histamine Antagonists; D009883:Ophthalmic Solutions